Efficacy News and Research

RSS
Vaccines protect more than mums-to-be, study shows

Vaccines protect more than mums-to-be, study shows

Smartphone nudges showed early promise for diabetes

Smartphone nudges showed early promise for diabetes

New hybrid approach intensifies treatment for liver tumor metastases

New hybrid approach intensifies treatment for liver tumor metastases

Drug combination shows long-term survival in advanced thymic cancer

Drug combination shows long-term survival in advanced thymic cancer

Telemedicine-based management program improves quality of life for heart failure patients

Telemedicine-based management program improves quality of life for heart failure patients

Personalized mobile health coaching reduces gestational diabetes among pregnant women

Personalized mobile health coaching reduces gestational diabetes among pregnant women

Multicenter trial validates continuous pregnancy-to-postpartum mobile health coaching program

Multicenter trial validates continuous pregnancy-to-postpartum mobile health coaching program

New salt-triggered gel makes bacterial cancer therapy much safer

New salt-triggered gel makes bacterial cancer therapy much safer

Chronic stress promotes oral cancer through a brain–immune pathway

Chronic stress promotes oral cancer through a brain–immune pathway

Oral leukemia therapy offers effective at-home care for older adults

Oral leukemia therapy offers effective at-home care for older adults

Experimental drug targets tumor barriers to unlock cancer-killing T cells

Experimental drug targets tumor barriers to unlock cancer-killing T cells

EU-funded project develops mRNA vaccine targeting liver cancer

EU-funded project develops mRNA vaccine targeting liver cancer

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

European commission approves label expansion of Pepaxti to third-line treatment

European commission approves label expansion of Pepaxti to third-line treatment

The Critical Role of Sample Storage in Drug Discovery and Development

The Critical Role of Sample Storage in Drug Discovery and Development

Most eligible teens miss out on advanced obesity treatments

Most eligible teens miss out on advanced obesity treatments

Blocking complement factor B halts pancreatic cancer growth

Blocking complement factor B halts pancreatic cancer growth

Qureight's fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight's fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Modified zinc finger protein reduces brain plaques in Alzheimer's mice

Modified zinc finger protein reduces brain plaques in Alzheimer's mice

Combat Medical reports 68% high-grade recurrence-free survival at 12 months in BCG-unresponsive non-muscle invasive bladder cancer study

Combat Medical reports 68% high-grade recurrence-free survival at 12 months in BCG-unresponsive non-muscle invasive bladder cancer study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.